Cardiovascular & Hematological Disorders-Drug Targets

Cardiovascular & Hematological Disorders-Drug Targets

Bari
Italy">Editor-in-Chief

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Back Subscribe
Research Article

Expression of PIM1/ASK1 Molecular Pathway Related Genes in Ischemic Cardiomyopathy

Author(s): Mohammadjavad Sotoudeheian, Seyed-Mohamad-Sadegh Mirahmadi, Navid Farahmandian, Mohammad Pirhayati, Reza Azarbad, Seyed Ahmad Hosseini and Hamidreza Pazoki Toroudi*

Volume 25, Issue 3, 2025

Published on: 11 June, 2025

Page: [207 - 220] Pages: 14

DOI: 10.2174/011871529X366280250526131550

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: Myocardial ischemia/reperfusion injuries (MI/RI) are responsible for fatal cardiovascular diseases. Myocardial infarction may lead to ischemic cardiomyopathy (ICM). Thereby, illustrating the MI/RI molecular basis could lead to the emergence of novel therapeutic options. PIM1/ASK1 (MAP3K5) pathway is well-known in renal ischemia/ reperfusion. PIM1 protein can promote autophagy after hypoxia.

Materials and Methods: We selected the dataset GSE46224 from the National Center of Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database for evaluation. This dataset was analyzed using tools such as the Kyoto Encyclopedia of Genes and Genomes, Gene- Codis, and BioGRID. Three groups of patients were selected from the dataset. ICM group (n=8), non-failing (NF) group (n=8), and non-ischemic cardiomyopathy (NICM) group (n=8) evaluated for 15 genes expression levels. P-value <0.05 is statistically significant.

Results: JAK1 showed significantly lower gene expression in the ICM group compared to the NF group (p-value = 0.012, difference = -6.24). ASK1 was also significantly down-regulated in the ICM group compared to the NF group (p-value =0.0159, difference = -1.478). In contrast, STAT5B and NF-κB were significantly up-regulated in the ICM group (STAT5B: p-value = 0.0238, difference = 2.388; NF-κB: p-value = 0.0158, difference = 1.11). The analysis of differences and the volcano plot confirmed these findings, highlighting key dysregulated genes in ICM.

Conclusion: In conclusion, ICM patients have altered ASK1 expression compared to NF individuals. The significant down-regulation of ASK1 and JAK1, along with the up-regulation of STAT5B and NF-κB, suggests that targeting ASK1 could be an important strategy to ameliorate ischemia-related cardiomyocyte damage.

Keywords: Heart failure, myocardial infarction, ischemia/reperfusion injury, cardiomyocyte, gene expression omnibus, apoptosis, gene ontology.

Graphical Abstract

[1]
Schirone, L.; Forte, M.; D’Ambrosio, L.; Valenti, V.; Vecchio, D.; Schiavon, S.; Spinosa, G.; Sarto, G.; Petrozza, V.; Frati, G.; Sciarretta, S. An overview of the molecular mechanisms associated with myocardial ischemic injury: State of the art and translational perspectives. Cells, 2022, 11(7), 1165.
[http://dx.doi.org/10.3390/cells11071165] [PMID: 35406729]
[2]
Tang, C.Y.; Lai, C.C.; Huang, P.H.; Yang, A.H.; Chiang, S.C.; Huang, P.C.; Tseng, K.W.; Huang, C.H. Magnolol reduces myocardial injury induced by renal ischemia and reperfusion. J. Chin. Med. Assoc., 2022, 85(5), 584-596.
[http://dx.doi.org/10.1097/JCMA.0000000000000727] [PMID: 35385419]
[3]
Piamsiri, C.; Maneechote, C.; Jinawong, K.; Arunsak, B.; Chunchai, T.; Nawara, W.; Kerdphoo, S.; Chattipakorn, S.C.; Chattipakorn, N. Chronic mitochondrial dynamic-targeted therapy alleviates left ventricular dysfunction by reducing multiple programmed cell death in post-myocardial infarction rats. Eur. J. Pharmacol., 2024, 977, 176736.
[http://dx.doi.org/10.1016/j.ejphar.2024.176736] [PMID: 38878877]
[4]
Zhao, T.; Wu, W.; Sui, L.; Huang, Q.; Nan, Y.; Liu, J.; Ai, K. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact. Mater., 2022, 7, 47-72.
[http://dx.doi.org/10.1016/j.bioactmat.2021.06.006] [PMID: 34466716]
[5]
Ajami, M.; Davoodi, S.H.; Habibey, R.; Namazi, N.; Soleimani, M.; Pazoki-Toroudi, H. Effect of DHA + EPA on oxidative stress and apoptosis induced by ischemia‐reperfusion in rat kidneys. Fundam. Clin. Pharmacol., 2013, 27(6), 593-602.
[http://dx.doi.org/10.1111/j.1472-8206.2012.01066.x] [PMID: 22943605]
[6]
Zhang, M.; Liu, Q.; Meng, H.; Duan, H.; Liu, X.; Wu, J.; Gao, F.; Wang, S.; Tan, R.; Yuan, J. Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther., 2024, 9(1), 12.
[http://dx.doi.org/10.1038/s41392-023-01688-x] [PMID: 38185705]
[7]
Li, T.; Tan, Y.; Ouyang, S.; He, J.; Liu, L. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene, 2022, 808, 145968.
[http://dx.doi.org/10.1016/j.gene.2021.145968] [PMID: 34530090]
[8]
Tursynbay, Y.; Zhang, J.; Li, Z.; Tokay, T.; Zhumadilov, Z.; Wu, D.; Xie, Y. Pim-1 kinase as cancer drug target: An update. Biomed. Rep., 2016, 4(2), 140-146.
[http://dx.doi.org/10.3892/br.2015.561] [PMID: 26893828]
[9]
Mahata, S.; Behera, S.K.; Kumar, S.; Sahoo, P.K.; Sarkar, S.; Fazil, M.H.U.T.; Nasare, V.D. In-silico and in-vitro investigation of STAT3-PIM1 heterodimeric complex: Its mechanism and inhibition by curcumin for cancer therapeutics. Int. J. Biol. Macromol., 2022, 208, 356-366.
[http://dx.doi.org/10.1016/j.ijbiomac.2022.03.137] [PMID: 35346675]
[10]
Santio, N.M.; Koskinen, P.J. PIM kinases: From survival factors to regulators of cell motility. Int. J. Biochem. Cell Biol., 2017, 93, 74-85.
[http://dx.doi.org/10.1016/j.biocel.2017.10.016] [PMID: 29108877]
[11]
Zhao, Y. A systematic review on active sites and functions of PIM-1 protein. Hum. Cell, 2022, 35(2), 1-14.
[http://dx.doi.org/10.1007/s13577-021-00656-3] [PMID: 35000143]
[12]
Zhao, X.Y.; Ren, J.M.; Liu, H.R.; Zhou, T.T.; Wang, X.Y.; Liu, S.; Chen, H.P. DJ-1 activates the AMPK/mTOR pathway by binding RACK1 to induce autophagy and protect the myocardium from ischemia/hypoxia injury. Biochem. Biophys. Res. Commun., 2022, 637, 276-285.
[http://dx.doi.org/10.1016/j.bbrc.2022.10.100] [PMID: 36410277]
[13]
Gu, J.J.; Wang, Z.; Reeves, R.; Magnuson, N.S. PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene, 2009, 28(48), 4261-4271.
[http://dx.doi.org/10.1038/onc.2009.276] [PMID: 19749799]
[14]
Wu, J.; Chu, E.; Kang, Y. Pim kinases in multiple myeloma. Cancers, 2021, 13(17), 4304.
[http://dx.doi.org/10.3390/cancers13174304] [PMID: 34503111]
[15]
Ajami, M.; Eghtesadi, S.; Razaz, J.M.; Kalantari, N.; Habibey, R.; Nilforoushzadeh, M.A.; Zarrindast, M.; Pazoki-Toroudi, H. Expression of Bcl-2 and Bax after hippocampal ischemia in DHA + EPA treated rats. Neurol. Sci., 2011, 32(5), 811-818.
[http://dx.doi.org/10.1007/s10072-011-0621-5] [PMID: 21617951]
[16]
Javedan, G.; Shidfar, F.; Davoodi, S.H.; Ajami, M.; Gorjipour, F.; Sureda, A.; Nabavi, S.M.; Daglia, M.; Pazoki-Toroudi, H. Conjugated linoleic acid rat pretreatment reduces renal damage in ischemia/reperfusion injury: Unraveling antiapoptotic mechanisms and regulation of phosphorylated mammalian target of rapamycin. Mol. Nutr. Food Res., 2016, 60(12), 2665-2677.
[http://dx.doi.org/10.1002/mnfr.201600112] [PMID: 27466783]
[17]
Wiza, C.; Nascimento, E.B.M.; Ouwens, D.M. Role of PRAS40 in Akt and mTOR signaling in health and disease. Am. J. Physiol. Endocrinol. Metab., 2012, 302(12), E1453-E1460.
[http://dx.doi.org/10.1152/ajpendo.00660.2011] [PMID: 22354785]
[18]
Chong, Z.Z. Targeting PRAS40 for multiple diseases. Drug Discov. Today, 2016, 21(8), 1222-1231.
[http://dx.doi.org/10.1016/j.drudis.2016.04.005] [PMID: 27086010]
[19]
Völkers, M.; Toko, H.; Doroudgar, S.; Din, S.; Quijada, P.; Joyo, A.Y.; Ornelas, L.; Joyo, E.; Thuerauf, D.J.; Konstandin, M.H.; Gude, N.; Glembotski, C.C.; Sussman, M.A. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. Proc. Natl. Acad. Sci. USA, 2013, 110(31), 12661-12666.
[http://dx.doi.org/10.1073/pnas.1301455110] [PMID: 23842089]
[20]
Zhou, Q.; Tang, S.; Zhang, X.; Chen, L. Targeting PRAS40: A novel therapeutic strategy for human diseases. J. Drug Target., 2021, 29(7), 703-715.
[http://dx.doi.org/10.1080/1061186X.2021.1882470] [PMID: 33504218]
[21]
Kim, W.; Youn, H.; Seong, K.M.; Yang, H.J.; Yun, Y.J.; Kwon, T.; Kim, Y.H.; Lee, J.Y.; Jin, Y.W.; Youn, B. PIM1-activated PRAS40 regulates radioresistance in non-small cell lung cancer cells through interplay with FOXO3a, 14-3-3 and protein phosphatases. Radiat. Res., 2011, 176(5), 539-552.
[http://dx.doi.org/10.1667/RR2609.1] [PMID: 21910584]
[22]
Obsilova, V.; Honzejkova, K.; Obsil, T. Structural insights support targeting ASK1 kinase for therapeutic interventions. Int. J. Mol. Sci., 2021, 22(24), 13395.
[http://dx.doi.org/10.3390/ijms222413395] [PMID: 34948191]
[23]
Luo, Y.; Zhu, J.; Zhao, F.; Shi, L.; Li, Y.; Wu, X. PIM1 attenuates renal ischemia–reperfusion injury by inhibiting ASK1-JNK/P38. Int. Immunopharmacol., 2023, 114, 109563.
[http://dx.doi.org/10.1016/j.intimp.2022.109563] [PMID: 36513021]
[24]
Yang, K.C.; Yamada, K.A.; Patel, A.Y.; Topkara, V.K.; George, I.; Cheema, F.H.; Ewald, G.A.; Mann, D.L.; Nerbonne, J.M. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation, 2014, 129(9), 1009-1021.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.113.003863] [PMID: 24429688]
[25]
Tymińska, A.; Ozierański, K.; Balsam, P.; Maciejewski, C.; Wancerz, A.; Brociek, E.; Marchel, M.; Crespo-Leiro, M.G.; Maggioni, A.P.; Drożdż, J.; Opolski, G.; Grabowski, M.; Kapłon-Cieślicka, A. Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction— clinical characteristics and prognosis depending on heart failure etiology (Data from European Society of Cardiology Heart Failure Registries). Biology, 2022, 11(2), 341.
[http://dx.doi.org/10.3390/biology11020341] [PMID: 35205207]
[26]
Lu, Y.; An, L.; Taylor, M.R.G.; Chen, Q.M. Nrf2 signaling in heart failure: Expression of Nrf2, Keap1, antioxidant, and detoxification genes in dilated or ischemic cardiomyopathy. Physiol. Genomics, 2022, 54(3), 115-127.
[http://dx.doi.org/10.1152/physiolgenomics.00079.2021] [PMID: 35073209]
[27]
Liu, X.; Qu, J.; Xue, W.; He, L.; Wang, J.; Xi, X.; Liu, X.; Yin, Y.; Qu, Y. Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 2018, 13, 1217-1228.
[http://dx.doi.org/10.2147/COPD.S163459] [PMID: 29713155]
[28]
Manchia, M.; Piras, I.S.; Huentelman, M.J.; Pinna, F.; Zai, C.C.; Kennedy, J.L.; Carpiniello, B. Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets. Eur. Neuropsychopharmacol., 2017, 27(10), 1054-1063.
[http://dx.doi.org/10.1016/j.euroneuro.2017.07.002] [PMID: 28732597]
[29]
Huang, Y.; Zhu, J.; Li, W.; Zhang, Z.; Xiong, P.; Wang, H.; Zhang, J. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Oncol. Rep., 2018, 39(3), 1338-1346.
[PMID: 29286167]
[30]
Zhang, Q.; Chen, W.; Chen, S.; Li, S.; Wei, D.; He, W. Identification of key genes and upstream regulators in ischemic stroke. Brain Behav., 2019, 9(7), e01319.
[http://dx.doi.org/10.1002/brb3.1319] [PMID: 31168961]
[31]
Dang, H.; Ye, Y.; Zhao, X.; Zeng, Y. Identification of candidate genes in ischemic cardiomyopathy by gene expression omnibus database. BMC Cardiovasc. Disord., 2020, 20(1), 320.
[http://dx.doi.org/10.1186/s12872-020-01596-w] [PMID: 32631246]
[32]
Xu, M.; Li, X.; Song, L. Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway. Pharm. Biol., 2020, 58(1), 655-663.
[http://dx.doi.org/10.1080/13880209.2020.1779318] [PMID: 32649845]
[33]
Xiaodong, Y.E.; Cai, Y.; Wang, T.; Li, X.; Wang, S.; Wu, Q.; Liu, D.; Irwin, M.G.; Xia, Z. Repeated remote ischemic preconditioning enhances post‐ischemic myocardial STAT5A and STAT3 but not STAT5B to confer cardioprotection in diabetic rats. FASEB J., 2020, 34(S1), 1.
[http://dx.doi.org/10.1096/fasebj.2020.34.s1.09040]
[34]
Broughton, K.; Korski, K.; Echeagaray, O.; Adamson, R.; Dembitsky, W.; Lu, Z.; Schaefer, E.; Sussman, M.A. Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells. Gene Ther., 2019, 26(7-8), 324-337.
[http://dx.doi.org/10.1038/s41434-019-0084-5] [PMID: 31239537]
[35]
Park, J.H.; Lee, N.K.; Lim, H.J.; Ji, S.; Kim, Y.J.; Jang, W.B.; Kim, D.Y.; Kang, S.; Yun, J.; Ha, J.; Kim, H.; Lee, D.; Baek, S.H.; Kwon, S.M. Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells. Exp. Mol. Med., 2020, 52(4), 615-628.
[http://dx.doi.org/10.1038/s12276-020-0374-4] [PMID: 32273566]
[36]
Braga, C.L.; Felix, N.S.; Teixeira, D.E.; Vieira, J.B.; Silva-Aguiar, R.P.; Bose, R.M.; Antunes, M.A.; Rocha, N.N.; Caruso-Neves, C.; Cruz, F.F.; Rocco, P.R.M.; Silva, P.L. Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension. Eur. J. Pharmacol., 2020, 887, 173438.
[http://dx.doi.org/10.1016/j.ejphar.2020.173438] [PMID: 32795515]
[37]
Casillas, A.L.; Chauhan, S.S.; Toth, R.K.; Sainz, A.G.; Clements, A.N.; Jensen, C.C.; Langlais, P.R.; Miranti, C.K.; Cress, A.E.; Warfel, N.A. Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors. Oncogene, 2021, 40(32), 5142-5152.
[http://dx.doi.org/10.1038/s41388-021-01915-1] [PMID: 34211090]
[38]
Janbandhu, V; Tallapragada, V; Patrick, R; Li, Y; Abeygunawardena, D Humphreys, DT Hif-1a suppresses ROSinduced proliferation of cardiac fibroblasts following myocardial infarction. Cell Stem Cell, 2022, 29(2), 281-297. e12.
[http://dx.doi.org/10.1016/j.stem.2021.10.009] [PMID: 34762860]
[39]
Garson, K-L. Elucidating the underlying mechanisms of benfotiamine-induced cardioprotection; Stellenbosch University: Stellenbosch, 2014.
[40]
Wang, S.; Sun, L.; Zhu, Z.; Liu, J.; Ge, W.; Li, B.; Wang, B. Cryptotanshinone alleviates myocardial ischemia and reperfusion injury in rats to mitigate ER stress-dependent apoptosis by modulating the JAK1/STAT3 axis. Am. J. Transl. Res., 2022, 14(7), 5024-5039.
[PMID: 35958489]
[41]
Jiang, H; Yang, J; Li, T; Wang, X; Fan, Z; Ye, Q; Du, Y. JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target. Front Pharmacol, 2024, Mar 1; 15: 1336102.
[http://dx.doi.org/10.3389/fphar.2024.1336102] [PMID: 38495094] [PMCID: PMC10940489]
[42]
Zhang, J.; Fu, L.; Zhang, J.; Zhou, B.; Tang, Y.; Zhang, Z.; Gu, T. Inhibition of microRNA-122-5p relieves myocardial ischemia-reperfusion injury via SOCS1. Hamostaseologie, 2023, 43(4), 271-280.
[http://dx.doi.org/10.1055/a-2013-0336] [PMID: 36882114]
[43]
Liu, Z.; Han, M.; Ding, K.; Fu, R. The role of Pim kinase in immunomodulation. Am. J. Cancer Res., 2020, 10(12), 4085-4097.
[PMID: 33414987]
[44]
Yang, X.; Liu, C.; Lei, Y.; Liu, Z.; Zhu, B.; Zhao, D. PIM1 signaling in immunoinflammatory diseases: An emerging therapeutic target. Front. Immunol., 2024, 15, 1443784.
[http://dx.doi.org/10.3389/fimmu.2024.1443784] [PMID: 39372407]
[45]
Mahata, S.; Sahoo, P.K.; Pal, R.; Sarkar, S.; Mistry, T.; Ghosh, S.; Nasare, V.D. PIM1/STAT3 axis: A potential co-targeted therapeutic approach in triple-negative breast cancer. Med. Oncol., 2022, 39(7), 74.
[http://dx.doi.org/10.1007/s12032-022-01675-2] [PMID: 35568774]
[46]
Tóthová, Z.; Tomc, J.; Debeljak, N.; Solár, P. STAT5 as a key protein of erythropoietin signalization. Int. J. Mol. Sci., 2021, 22(13), 7109.
[http://dx.doi.org/10.3390/ijms22137109] [PMID: 34281163]
[47]
Ding, W.; Feng, H.; Li, W.J.; Liao, H.H.; Zhang, N.; Zhou, Z.Y.; Mou, S.Q.; Lin, Z.; Xia-He, N.Z.; Xia, H.; Tang, Q.Z. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling. Eur. J. Pharmacol., 2021, 909, 174402.
[http://dx.doi.org/10.1016/j.ejphar.2021.174402] [PMID: 34348125]
[48]
Liu, F.; Fan, L.M.; Geng, L.; Li, J.M. p47phox-dependent oxidant signalling through ASK1, MKK3/6 and MAPKs in angiotensin II-induced cardiac hypertrophy and apoptosis. Antioxidants, 2021, 10(9), 1363.
[http://dx.doi.org/10.3390/antiox10091363] [PMID: 34572995]
[49]
Wang, X.; Nie, X.; Wang, H.; Ren, Z. Roles of small GTPases in cardiac hypertrophy (Review). Mol. Med. Rep., 2024, 30(5), 208.
[http://dx.doi.org/10.3892/mmr.2024.13332] [PMID: 39301654]
[50]
Wan, H.; Zhang, J.; Liu, Z.; Dong, B.; Tao, Z.; Wang, G.; Wang, C. RING finger protein 5 protects against acute myocardial infarction by inhibiting ASK1. BMC Cardiovasc. Disord., 2024, 24(1), 406.
[http://dx.doi.org/10.1186/s12872-024-04070-z] [PMID: 39098896]
[51]
Chen, H.; Zhou, H.; Yang, J.; Wan, H.; He, Y. Guhong injection mitigates myocardial ischemia/reperfusion injury by activating GST P to inhibit ASK1-JNK/p38 pathway. Phytomedicine, 2023, 109, 154603.
[http://dx.doi.org/10.1016/j.phymed.2022.154603] [PMID: 36610111]
[52]
Huang, K.; Cai, C.; He, H.; Yi, B.; Xu, W.; Lin, Z.; Lv, X.; Liu, R.; Zheng, C.; Zhou, Y.; Lin, J. Promotion of Raf-1/ASK1 complex formation by corylin inhibits cell apoptosis in myocardial ischemia/reperfusion injury. Int. Immunopharmacol., 2024, 140, 112921.
[http://dx.doi.org/10.1016/j.intimp.2024.112921] [PMID: 39133953]
[53]
Aziz, A.; Farid, S.; Qin, K.; Wang, H.; Liu, B. PIM kinases and their relevance to the PI3K/AKT/mTOR pathway in the regulation of ovarian cancer. Biomolecules, 2018, 8(1), 7.
[http://dx.doi.org/10.3390/biom8010007] [PMID: 29401696]
[54]
Borillo, G.A.; Mason, M.; Quijada, P.; Völkers, M.; Cottage, C.; McGregor, M.; Din, S.; Fischer, K.; Gude, N.; Avitabile, D.; Barlow, S.; Alvarez, R.; Truffa, S.; Whittaker, R.; Glassy, M.S.; Gustafsson, A.B.; Miyamoto, S.; Glembotski, C.C.; Gottlieb, R.A.; Brown, J.H.; Sussman, M.A. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ. Res., 2010, 106(7), 1265-1274.
[http://dx.doi.org/10.1161/CIRCRESAHA.109.212035] [PMID: 20203306]
[55]
Frati, G.; Versaci, F.; Sciarretta, S. A novel signalling mechanism regulating telomere length in cardiomyocytes; Oxford University Press, 2021, pp. 13-14.
[56]
Samse, K.; Emathinger, J.; Hariharan, N.; Quijada, P.; Ilves, K.; Völkers, M.; Ormachea, L.; De La Torre, A.; Orogo, A.M.; Alvarez, R.; Din, S.; Mohsin, S.; Monsanto, M.; Fischer, K.M.; Dembitsky, W.P.; Gustafsson, Å.B.; Sussman, M.A. Functional effect of Pim1 depends upon intracellular localization in human cardiac progenitor cells. J. Biol. Chem., 2015, 290(22), 13935-13947.
[http://dx.doi.org/10.1074/jbc.M114.617431] [PMID: 25882843]
[57]
Zhu, H.; Wang, X.; Sun, Y.; He, W.; Liang, J.; Mo, B.; Li, L. Pim1 overexpression prevents apoptosis in cardiomyocytes after exposure to hypoxia and oxidative stress via upregulating cell autophagy. Cell. Physiol. Biochem., 2018, 49(6), 2138-2150.
[http://dx.doi.org/10.1159/000493817] [PMID: 30257237]

Rights & Permissions Print Cite